Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
| Autor: | Campone, M. 1, 2, *, Bondarenko, I. 3, Brincat, S. 4, Hotko, Y. 5, Munster, P.N. 6, †, Chmielowska, E. 7, Fumoleau, P. 8, Ward, R. 9, ‡, Bardy-Bouxin, N. 10, Leip, E. 11, Turnbull, K. 11, Zacharchuk, C. 11, Epstein, R.J. 12, § |
|---|---|
| Zdroj: | In Annals of Oncology March 2012 23(3):610-617 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|